BioPharm News

Oct 30, 2018
By BioPharm International Editors
The acquisition will allow Lonza to further develop technology for scalable autologous cell-therapy manufacturing.
Oct 30, 2018
By BioPharm International Editors
Kimberly-Clark Professional added the Kimtech A5 Sterile Integrated Hood and Mask XL for head shapes, sizes, and hairstyles that pose a challenge to standard aseptic gowning for cleanroom operators.
Oct 29, 2018
By BioPharm International Editors
The latest CPhI Worldwide survey results have revealed a promising outlook for the global pharma economies.
Oct 26, 2018
By BioPharm International Editors
The company added a new EUR 63-million (US$72-million) packaging center at its manufacturing site in Darmstadt, Germany.
Oct 26, 2018
By BioPharm International Editors
Research from Massachusetts Institute of Technology suggests that small chips could replace standard lab-scale spectrometry equipment for many applications.
Oct 26, 2018
By BioPharm International Editors
AbbVie will assume full development and commercial responsibility for its collaboration with Galapagos to discover and develop new therapies to treat cystic fibrosis (CF).
Oct 25, 2018
By BioPharm International Editors
The investment in the company’s Mississauga, Canada, laboratory includes an expansion of existing cell/tissue culture capabilities, flow cytometry, mass spectrometry facilities, and more.
Oct 24, 2018
By BioPharm International Editors
The company will complete an expansion of its secondary packaging capabilities at its Ravensburg, Germany site by 2020.
Oct 24, 2018
By BioPharm International Editors
AstraZeneca and Innate Pharma further expand oncology collaboration with a new multi-term agreement.
Oct 23, 2018
By BioPharm International Editors
Takhzyro (lanadelumab) is the first monoclonal antibody therapy approved for the prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
native1_300x100
lorem ipsum